ImmuCell to Raise Money to Complete Construction

October 24, 2016 01:41 PM

A Portland, Maine company that makes products to improve bovine health and productivity of dairy and beef industries has secured additional funding to complete a new production facility.

ImmuCell Corp. announced Friday that it had secured $3.2 million in net proceeds through a stock offering to help fund a $20 million production facility for a new product.

The company says the new facility is needed to produce the active ingredient in a product aimed at treating dairy cows with mastitis, an inflammation of the udders that is often caused by a bacterial infection. The company is seeking U.S. Food and Drug Administration approval.

Immucell, which is Maine's smallest publicly traded company, already spent about $650,000 on the project on construction which began Oct. 11.

Back to news



Spell Check

No comments have been posted to this News Article

Corn College TV Education Series


Get nearly 8 hours of educational video with Farm Journal's top agronomists. Produced in the field and neatly organized by topic, from spring prep to post-harvest. Order now!


Market Data provided by
Brought to you by Beyer